Timing Is Everything.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 28076761.
- Also identified by DOI 10.1016/j.cmet.2016.12.015.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In a recent issue of Cancer Cell, Kettner and colleagues (2016) link disruption of normal circadian rhythms to NASH and associated liver cancer, suggesting that molecular clocks, as well as their regulators and target genes, might provide novel therapeutic targets in these diseases.
Medical subject headings
- Circadian Rhythm
- Liver Neoplasms